drugset / Trial / NCT00240370

A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics

NCT00240370

Phase 3 Completed 1159 enrolled Bristol-Myers Squibb
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate if type 2 diabetics who have inadequate glycemic control on metformin alone, have a similar, or not inferior, glycemic response when treated with the combination of muraglitazar and metformin compared to pioglitazone and metformin.

Timeline

Start
2003-10
Primary completion
2005-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Muraglitazar Small molecule